DKA missed in patients taking SGLT2 inhibitors, SA review finds

Doctors and patients are not recognising early signs of diabetic ketoacidosis triggered by SGLT2 inhibitors, a review of 13 cases in South Australia has shown. The life-threatening condition was often being missed due to relative euglycaemia, resulting in delayed treatment, according to a report by endocrinologist Dr Emily Mayer and colleagues at the Royal Adelaide ...

Already a member?

Login to keep reading.

© 2021 the limbic